Suppr超能文献

通过纳米医学增强联合免疫治疗和放射治疗。

Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine.

机构信息

Laboratory of Nano- and Translational Medicine, Lineberger Comprehensive Cancer Center, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

出版信息

Bioconjug Chem. 2020 Dec 16;31(12):2668-2678. doi: 10.1021/acs.bioconjchem.0c00520. Epub 2020 Nov 30.

Abstract

Radiotherapy and immunotherapy are two key treatments for cancer. There is growing evidence that they are also synergistic, and combination treatments are being studied extensively in the clinical setting. In addition, there is emerging evidence that nanotechnology-enabled therapeutics can potentiate both radiotherapy and immunotherapy, in turn improving both treatments. This is an exciting new area of interdisciplinary science and has significant potential for major clinical impact. Some of the approaches in this area have already reached the clinical stage. In this review, we will discuss recent advances in the interface between radiotherapy, immunotherapy, and nanomedicine. We plan to review the many approaches to combine these three fields for cancer treatment.

摘要

放疗和免疫疗法是癌症的两种主要治疗方法。越来越多的证据表明,它们也是协同作用的,联合治疗正在临床中广泛研究。此外,有新的证据表明,纳米技术使能的治疗方法可以增强放疗和免疫疗法的效果,从而改善这两种治疗方法。这是一个令人兴奋的新的跨学科科学领域,具有重大的临床影响潜力。该领域的一些方法已经进入临床阶段。在这篇综述中,我们将讨论放疗、免疫疗法和纳米医学之间的界面的最新进展。我们计划回顾将这三个领域结合起来治疗癌症的多种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5a/7747221/1530ac54858c/bc0c00520_0001.jpg

相似文献

1
Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine.
Bioconjug Chem. 2020 Dec 16;31(12):2668-2678. doi: 10.1021/acs.bioconjchem.0c00520. Epub 2020 Nov 30.
2
Nanotechnology in the arena of cancer immunotherapy.
Arch Pharm Res. 2020 Jan;43(1):58-79. doi: 10.1007/s12272-020-01207-4. Epub 2020 Jan 19.
3
Sonodynamic therapy-derived multimodal synergistic cancer therapy.
Cancer Lett. 2021 Jan 28;497:229-242. doi: 10.1016/j.canlet.2020.10.037. Epub 2020 Oct 27.
4
Combining Nanomedicine and Immunotherapy.
Acc Chem Res. 2019 Jun 18;52(6):1543-1554. doi: 10.1021/acs.accounts.9b00148. Epub 2019 May 23.
5
Integrating nanomedicine into clinical radiotherapy regimens.
Adv Drug Deliv Rev. 2019 Apr;144:35-56. doi: 10.1016/j.addr.2019.07.002. Epub 2019 Jul 4.
6
Advanced nanotechnology: An arsenal to enhance immunotherapy in fighting cancer.
Clin Chim Acta. 2019 May;492:12-19. doi: 10.1016/j.cca.2019.01.027. Epub 2019 Jan 31.
7
Advances in engineering local drug delivery systems for cancer immunotherapy.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Sep;12(5):e1632. doi: 10.1002/wnan.1632. Epub 2020 Apr 7.
8
Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
Trends Biotechnol. 2017 Jul;35(7):665-676. doi: 10.1016/j.tibtech.2017.03.004. Epub 2017 Mar 29.
9
Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.
ACS Nano. 2018 Jan 23;12(1):24-43. doi: 10.1021/acsnano.7b05108. Epub 2017 Dec 22.
10
Emerging nanotechnologies for cancer immunotherapy.
Exp Biol Med (Maywood). 2016 May;241(10):1116-26. doi: 10.1177/1535370216647123. Epub 2016 May 4.

引用本文的文献

1
PRIMERS: Polydopamine Radioimmunotherapy with Image-Guided Monitoring and Enhanced Release System.
Pharmaceutics. 2024 Nov 20;16(11):1481. doi: 10.3390/pharmaceutics16111481.
2
Cancer immunotherapy and its facilitation by nanomedicine.
Biomark Res. 2024 Aug 3;12(1):77. doi: 10.1186/s40364-024-00625-6.
3
Current research trends of nanomedicines.
Acta Pharm Sin B. 2023 Nov;13(11):4391-4416. doi: 10.1016/j.apsb.2023.05.018. Epub 2023 May 20.
4
Nanoparticles augment the therapeutic window of RT and immunotherapy for treating cancers: pivotal role of autophagy.
Theranostics. 2023 Jan 1;13(1):40-58. doi: 10.7150/thno.77233. eCollection 2023.
5
Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications.
Micromachines (Basel). 2022 Dec 14;13(12):2217. doi: 10.3390/mi13122217.
6
Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy.
Front Bioeng Biotechnol. 2022 Sep 8;10:1010724. doi: 10.3389/fbioe.2022.1010724. eCollection 2022.
7
3D printed drug-loaded implantable devices for intraoperative treatment of cancer.
J Control Release. 2022 Apr;344:147-156. doi: 10.1016/j.jconrel.2022.02.024. Epub 2022 Feb 22.

本文引用的文献

4
NIR-Triggered Phototherapy and Immunotherapy via an Antigen-Capturing Nanoplatform for Metastatic Cancer Treatment.
Adv Sci (Weinh). 2019 Mar 13;6(10):1802157. doi: 10.1002/advs.201802157. eCollection 2019 May 17.
5
Fluorescence imaging guided CpG nanoparticles-loaded IR820-hydrogel for synergistic photothermal immunotherapy.
Biomaterials. 2019 Jul;209:111-125. doi: 10.1016/j.biomaterials.2019.04.024. Epub 2019 Apr 22.
6
Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
Nat Biomed Eng. 2018 Aug;2(8):600-610. doi: 10.1038/s41551-018-0203-4. Epub 2018 Mar 26.
7
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination.
Nat Med. 2019 May;25(5):814-824. doi: 10.1038/s41591-019-0410-x. Epub 2019 Apr 8.
8
Emerging Nano-/Microapproaches for Cancer Immunotherapy.
Adv Sci (Weinh). 2019 Jan 13;6(6):1801847. doi: 10.1002/advs.201801847. eCollection 2019 Mar 20.
9
Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy.
ACS Nano. 2019 Apr 23;13(4):4028-4040. doi: 10.1021/acsnano.8b08177. Epub 2019 Mar 27.
10
Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy.
J Control Release. 2019 Apr 28;300:154-160. doi: 10.1016/j.jconrel.2019.02.036. Epub 2019 Mar 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验